These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 23388733
1. Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantation. Courivaud C, Bamoulid J, Loupy A, Deschamps M, Ferrand C, Simula-Faivre D, Tiberghien P, Chalopin JM, Legendre C, Thervet E, Borg C, Saas P, Ducloux D. Transplantation; 2013 Mar 15; 95(5):728-32. PubMed ID: 23388733 [Abstract] [Full Text] [Related]
2. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype. Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Göke B, Ochsenkühn T, Lohse P. Am J Gastroenterol; 2006 Jan 15; 101(1):99-106. PubMed ID: 16405540 [Abstract] [Full Text] [Related]
3. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease. Sabate JM, Ameziane N, Lamoril J, Jouet P, Farmachidi JP, Soulé JC, Harnois F, Sobhani I, Jian R, Deybach JC, de Prost D, Coffin B. Eur J Gastroenterol Hepatol; 2008 Aug 15; 20(8):748-55. PubMed ID: 18617779 [Abstract] [Full Text] [Related]
4. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity. Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D, Laprise C. Obesity (Silver Spring); 2011 Jan 15; 19(1):222-7. PubMed ID: 20523302 [Abstract] [Full Text] [Related]
5. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. Hattori H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N. Neurosci Lett; 2005 Feb 10; 374(2):132-5. PubMed ID: 15644279 [Abstract] [Full Text] [Related]
6. Association study between the CX3CR1 gene and asthma. Tremblay K, Lemire M, Provost V, Pastinen T, Renaud Y, Sandford AJ, Laviolette M, Hudson TJ, Laprise C. Genes Immun; 2006 Dec 10; 7(8):632-9. PubMed ID: 17082760 [Abstract] [Full Text] [Related]
7. Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease. Yadav AK, Kumar V, Jha V. Indian J Nephrol; 2016 Dec 10; 26(4):275-9. PubMed ID: 27512300 [Abstract] [Full Text] [Related]
8. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors. Nassar BA, Nanji AA, Ransom TP, Rockwood K, Kirkland SA, Macpherson K, Connelly PW, Johnstone DE, O'Neill BJ, Bata IR, Andreou P, Title LM. Scand J Clin Lab Invest; 2008 Dec 10; 68(4):286-91. PubMed ID: 18609106 [Abstract] [Full Text] [Related]
9. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients. Dimberg J, Dienus O, Löfgren S, Hugander A, Wågsäter D. Int J Colorectal Dis; 2007 Oct 10; 22(10):1195-200. PubMed ID: 17611763 [Abstract] [Full Text] [Related]
10. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation. Niessner A, Marculescu R, Haschemi A, Endler G, Zorn G, Weyand CM, Maurer G, Mannhalter C, Wojta J, Wagner O, Huber K. Thromb Haemost; 2005 May 10; 93(5):949-54. PubMed ID: 15886814 [Abstract] [Full Text] [Related]
12. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma. Mühlbauer M, Ringel S, Hartmann A, Lallinger G, Weiss TS, Gäbele E, Wünsch PH, Schölmerich J, Hellerbrand C. Oncol Rep; 2005 May 10; 13(5):957-63. PubMed ID: 15809764 [Abstract] [Full Text] [Related]
13. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. Wasmuth HE, Zaldivar MM, Berres ML, Werth A, Scholten D, Hillebrandt S, Tacke F, Schmitz P, Dahl E, Wiederholt T, Hellerbrand C, Berg T, Weiskirchen R, Trautwein C, Lammert F. J Hepatol; 2008 Feb 10; 48(2):208-15. PubMed ID: 18078680 [Abstract] [Full Text] [Related]
14. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Marasini B, Cossutta R, Selmi C, Pozzi MR, Gardinali M, Massarotti M, Erario M, Battaglioli L, Biondi ML. Clin Dev Immunol; 2005 Dec 10; 12(4):275-9. PubMed ID: 16584113 [Abstract] [Full Text] [Related]
15. Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis. Bagci B, Bagci G, Huzmeli C, Sezgin I, Ozdemir O. Int Urol Nephrol; 2016 Jul 10; 48(7):1163-70. PubMed ID: 27118566 [Abstract] [Full Text] [Related]
16. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease. Matzhold EM, Trummer O, Grünbacher G, Zulus B, Boehm BO, März W, Renner W. Cytokine; 2009 Sep 10; 47(3):224-7. PubMed ID: 19628406 [Abstract] [Full Text] [Related]
17. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis. Stojković L, Djurić T, Stanković A, Dinčić E, Stančić O, Veljković N, Alavantić D, Zivković M. J Neuroimmunol; 2012 Apr 10; 245(1-2):87-92. PubMed ID: 22261545 [Abstract] [Full Text] [Related]
18. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. Amanatidou V, Sourvinos G, Apostolakis S, Tsilimigaki A, Spandidos DA. Pediatr Infect Dis J; 2006 May 10; 25(5):410-4. PubMed ID: 16645504 [Abstract] [Full Text] [Related]
19. Association between the CX3CR1 gene V249I polymorphism and delayed kidney allograft function. Dabrowska-Zamojcin E, Dziedziejko V, Safranow K, Kurzawski M, Domanski L, Pawlik A. Transpl Immunol; 2015 Jun 10; 32(3):172-4. PubMed ID: 25898802 [Abstract] [Full Text] [Related]
20. Association of V249I and T280M variants of fractalkine receptor CX3CR1 with carotid intima-media thickness in a mexican population with type 2 diabetes. Gómez-Díaz RA, Gutiérrez J, Contreras-Rodriguez A, Valladares-Salgado A, Tanus-Hajj J, Mondragón-González R, Talavera JO, Mejía-Benitez MA, García-Mena J, Cruz M, Wacher NH. Gac Med Mex; 2017 Jun 10; 153(1):49-56. PubMed ID: 28128806 [Abstract] [Full Text] [Related] Page: [Next] [New Search]